Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Prestige Consumer Healthcare (PBH)

NYSE Health Care Pharmaceuticals S&P SmallCap 600
$42.98
-1.34 (-3.02%)
Close of Nov 06, 2026 · end-of-day data
Source: Prestige Consumer Healthcare's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue$882.06M$1.04B$975.78M$963.01M$943.37M$1.09B$1.13B$1.13B$1.14B$1.09B
Cost of revenue$381.77M$464.67M$420.20M$410.79M$395.89M$466.17M$502.43M$500.91M$503.30M$493.13M
Gross profit$500.29M$576.50M$555.58M$552.22M$547.47M$620.65M$625.29M$624.45M$634.46M$595.58M
Operating income$205.64M$215.47M$67.50M$291.15M$297.40M$329.92M-$22.41M$342.43M$336.77M$309.41M
Interest expense$93.55M$106.27M$105.08M$96.22M$82.33M$64.29M$4.40M$5.20M$1.80M—
Pre-tax income$110.85M$107.09M-$38.05M$191.15M$204.11M$262.46M-$93.92M$276.02M$284.19M$257.50M
Income tax$41.45M-$232.48M-$2.25M$48.87M$39.43M$57.08M-$11.61M$66.69M$69.58M$67.19M
Net income$69.39M$339.57M-$35.80M$142.28M$164.68M$205.38M-$82.31M$209.34M$214.60M$190.30M
EBITDA$231.44M$248.90M$99.28M$320.15M$327.57M$362.01M$10.21M$373.10M$366.95M$340.68M
EPS (basic)$1.31$6.40$-0.69$2.81$3.28$4.09$-1.65$4.21$4.32$3.93
EPS (diluted)$1.30$6.34$-0.69$2.78$3.25$4.04$-1.65$4.17$4.29$3.91
Diluted shares53.36M53.53M52.07M51.14M50.60M50.84M49.89M50.18M50.08M48.72M
Gross margin56.7%55.4%56.9%57.3%58.0%57.1%55.4%55.5%55.8%54.7%
Operating margin23.3%20.7%6.9%30.2%31.5%30.4%-2.0%30.4%29.6%28.4%
Net margin7.9%32.6%-3.7%14.8%17.5%18.9%-7.3%18.6%18.9%17.5%

Balance sheet

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash & equivalents$41.85M$32.55M$27.53M$94.76M$32.30M$27.18M$58.49M$46.47M$97.88M$63.87M
Receivables$136.74M$140.88M$148.79M$150.52M$114.67M$139.33M$167.02M$176.78M$194.29M$191.92M
Inventory$115.61M$118.55M$119.88M$116.03M$114.96M$120.34M$162.12M$138.72M$147.71M$159.13M
Total current assets$334.43M$303.48M$300.94M$365.65M$269.83M$293.27M$391.74M$375.04M$448.33M$431.48M
Goodwill$615.25M$620.10M$578.58M$575.18M$578.08M$578.98M$527.55M$527.73M$527.42M$581.11M
Total assets$3.91B$3.76B$3.44B$3.51B$3.43B$3.67B$3.35B$3.32B$3.40B$3.49B
Total current liabilities$162.01M$123.20M$126.98M$149.88M$122.14M$143.42M$160.72M$117.05M$106.62M$120.92M
Short-term debt————$0————$0
Long-term debt$2.19B$1.99B$1.80B$1.73B$1.48B$1.48B$1.35B$1.14B$992.36M$993.95M
Total debt$2.19B$1.99B$1.80B$1.73B$1.48B$1.48B$1.35B$1.14B$992.36M$993.95M
Total liabilities$3.09B$2.58B$2.35B$2.34B$2.07B$2.09B$1.91B$1.66B$1.57B$1.61B
Shareholders' equity$822.55M$1.18B$1.10B$1.17B$1.36B$1.58B$1.45B$1.66B$1.83B$1.89B

Cash flow

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow$148.67M$210.11M$189.28M$217.12M$235.61M$259.92M$229.72M$248.93M$251.51M$257.63M
Capital expenditures$2.98M$12.53M$10.48M$14.56M$22.24M$9.64M$7.78M$9.55M$8.22M$11.18M
Free cash flow$145.69M$197.58M$178.80M$202.56M$213.36M$250.28M$221.93M$239.38M$243.29M$246.45M
Investing cash flow-$694.60M-$11.56M$55.43M-$16.57M-$22.24M-$256.51M-$11.58M-$20.11M-$17.45M-$136.84M
Financing cash flow$560.96M-$208.96M-$249.33M-$131.43M-$279.42M-$7.57M-$185.85M-$241.01M-$182.07M-$156.06M
Share buybacks$0$0$49.98M$56.72M$11.87M$0$50.00M$25.00M$51.51M$156.28M
Stock-based compensation$8.15M$8.91M$7.44M$7.64M$8.54M$9.04M$12.40M$14.01M$11.16M$10.84M
Depreciation & amortization$25.79M$33.43M$31.78M$29.00M$30.16M$32.09M$32.62M$30.68M$30.17M$31.27M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.